In a world where cloning and gene splicing are common practices, the possible extension of such tasks into the human realm becomes an issue. This is not the world of tomorrow – it is the world of today. In Next, Michael Chrichton takes a detour from the realm of science fiction to the realm of science fact. While the stories that take place in his novel are extreme cases, they are still theoretically possible with today's technology.
The corruption of the business realm is extending more and more into the realm of science. Studies that would once have gone unquestioned are now traced in order to determine whether their results were manipulated by corporations. This corruption takes a darker tone when experimentation with gene therapy and hybridization become a distinct moneymaking opportunity. The questions of ethics and safety go largely unconsidered as companies secretly bypass FDA protocol.
A gene is synthesized which has the distinct capability to remove addictions to various substances. Nicotine, heroin and even the spending of money are possible for treatment. The market for such a gene is a rich one indeed. Besides, is it not one's duty to serve the good of the public with such a life-saving drug, even if it means bending government policy? Testing on animal subjects has seen amazing results; moving on to humans is only logical.
This is only one of many cases Chrichton analyzes in his novel. In another drift from his usual style, Next is told as a group of short stories with chapters from each one interspersed throughout. The startling conclusion brings all of these stories together. This is one psychological thriller not a soul should miss.
READ MORE
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment